Portola Pharmaceuticals Enters Into Licensing Agreements for Investigational Agent Andexanet Alfa in Japan Worth Up to $120 Million
Go back to Portola Pharmaceuticals Enters Into Licensing Agreements for Investigational Agent Andexanet Alfa in Japan Worth Up to $120 Million| PORTOLA PHARMAC (NASDAQ: PTLA) | Delayed: 18.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.03 | 52 Week High | $52.89 | |||
| Open | $0.13 | 52 Week Low | $15.68 | |||
| Day High | $18.03 | P/E | 41.93 | |||
| Day Low | $18.03 | EPS | $0.43 | |||
| Volume | 15 | |||||
